Results 1 to 10 of about 2,770 (170)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma [PDF]

Journal of Hepatocellular Carcinoma, 2023
Chun-Yen Yu,1,* Po-Hsun Huang,1,* Leo Leung-Chit Tsang,1 Hsien-Wen Hsu,1 Wei-Xiong Lim,1 Ching-Chun Weng,1 Tung-Liang Huang,1 Chien-Chin Hsu,2 Chao-Long Chen,3 Hsin-You Ou,1 Yu-Fan Cheng1 1Department of Diagnostic Radiology, Kaohsiung Chang Gung ...
Yu CY, Huang PH, Tsang LLC, Hsu HW, Lim WX, Weng CC, Huang TL, Hsu CC, Chen CL, Ou HY, Cheng YF   +10 more
doaj   +4 more sources

Single-system outcomes after adopting yttrium-90 radioembolization with personalized dosimetry as the primary treatment approach for unresectable, solitary hepatocellular carcinoma [PDF]

ESMO Gastrointestinal Oncology
Background: Yittrium-90 (90Y) radioembolization has emerged as a secondary treatment option for early- to intermediate-stage hepatocellular carcinoma (HCC) in the Barcelona Clinic Liver Cancer (BCLC) Staging and Treatment Algorithm.
A. Zamani, K. Núñez, T. Sandow, J. Gimenez, A. Cohen, P. Thevenot   +5 more
doaj   +2 more sources

Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study [PDF]

Frontiers in Oncology, 2023
ObjectiveTo report the incidence of radiation pneumonitis after radioembolization.MethodsIn this retrospective study, from May 2009 to July 2021, 782 consecutive patients underwent radioembolization in two institutes.
Hyo-Cheol Kim, Gyoung Min Kim
doaj   +2 more sources

Yttrium-90 Radioembolization for Hepatic Metastases Secondary to Thymic Malignancies: A Case Report [PDF]

JTO Clinical and Research Reports
The current guidelines for the treatment of extrathoracic metastases secondary to thymic neoplasms recommend chemotherapy. Thymic carcinomas are radiosensitive, and radiation therapy is recommended for intrathoracic masses and isolated metastases that ...
Gavin Yuan, BA, Elena N. Petre, MD, Etay Ziv, MD, PhD, Brett Marinelli, MD, Ken Zhao, MD, Vlasios Sotirchos, MD, Erica S. Alexander, MD   +6 more
doaj   +2 more sources

Yttrium-90 radioembolization for treatment of anaplastic meningioma liver metastases [PDF]

Radiology Case Reports
Meningiomas are the most common primary intracranial neoplasm. The WHO classification, focusing on histomorphologic and molecular features, distinguishes WHO grade -1, -2, and -3 tumors.
Mohammad-Kasim Fassia, Arsalan Haghdel, Fred Pelzman, Rajiv Magge, Susan Pannullo, Benjamin Liechty, Theodore H. Schwartz, Jonathan P.S. Knisely, Jana Ivanidze, Brian Currie   +9 more
doaj   +2 more sources

Yttrium-90 Radioembolization Versus Transarterial Embolization for Lung Carcinoid Hepatic Metastasis [PDF]

JTO Clinical and Research Reports
Objective: To compare the safety and efficacy of transarterial embolization (TAE) and transarterial radioembolization (TARE) in the treatment of lung carcinoid liver metastasis.
Gavin Yuan, MD, Marios Platon Dimopoulos, MSc, MD, Elena N. Petre, MD, Etay Ziv, MD, PhD, Constantinos T. Sofocleous, MD, PhD, Lee Rodriguez, MPH, Alissa Cooper, MD, Vlasios Sotirchos, MD, Ken Zhao, MD, Adrian Gonzalez Aguirre, MD, Erica S. Alexander, MD   +10 more
doaj   +2 more sources

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings

Asian Journal of Surgery, 2016
Background: Radioembolization with yttrium microspheres is an established therapeutic modality for primary and secondary hepatic malignancies, with studies demonstrating improved overall survival.
Desmond Yip, Sagun Parakh, Sivakumar Gananadha   +2 more
exaly   +3 more sources

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer

Frontiers in Oncology, 2014
Liver metastases from colorectal cancer (CRC) result in substantial morbidity and mortality. The primary treatment is systemic chemotherapy, and in selected patients, surgical resection; however, for patients who are not surgical candidates and/or fail ...
Suvranu Ganguli, Muhammad Shaalan Beg, Sanjeeva Kalva   +2 more
exaly   +3 more sources

Yttrium-90 radioembolization for primary and metastatic liver tumors exhibiting arterial-phase hypovascularity [PDF]

Scientific Reports
To investigate dosimetry-derived tumor-to-perfused normal tissue ratio (T/N) and corresponding clinical outcomes of patients receiving yttrium-90 radioembolization with glass microspheres for tumors identified as hypovascular on arterial-phase cross ...
Mira Malavia, Grace Eliason, Lucas A. Eggers, Alex Arne, Katherine Marchak, James Hart, Jonathan Lindquist, Premal Trivedi, Leigh Casadaban   +8 more
doaj   +2 more sources

Severe bile duct complication after yttrium-90 radioembolization therapy in a patient with recurrent hepatocellular carcinoma after liver transplantation: A case report

Liver Research, 2021
Patients with recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) have a poor prognosis owing to rapid tumor progression.
Jian-Wen Zhang, Zhen-Yu Yu, Hai-Bo Li, Shu-Hong Yi, Wei Liu, Yang Yang, Guo-Ying Wang   +6 more
doaj   +1 more source